0001569052-21-000004.txt : 20211015
0001569052-21-000004.hdr.sgml : 20211015
20211015143503
ACCESSION NUMBER: 0001569052-21-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211015
DATE AS OF CHANGE: 20211015
EFFECTIVENESS DATE: 20211015
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Angiocrine Bioscience, Inc.
CENTRAL INDEX KEY: 0001569052
IRS NUMBER: 460855286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-417171
FILM NUMBER: 211325766
BUSINESS ADDRESS:
STREET 1: 11575 SORRENTO VALLEY RD, STE 217
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-436-8047
MAIL ADDRESS:
STREET 1: 11575 SORRENTO VALLEY RD, STE 217
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001569052
Angiocrine Bioscience, Inc.
11575 SORRENTO VALLEY RD, STE 217
SAN DIEGO
CA
CALIFORNIA
92121
(877) 784-8496
DELAWARE
None
None
Corporation
true
Marc
Cohen
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Director
Jeffrey
Port
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Director
Paul
Finnegan
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Chief Executive Officer
Jeff
Jonas
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Director
David
Parkinson
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Director
John
Jaskowiak
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Executive Officer
Chief Operating Officer, Secretary
John
Lomoro
11575 Sorrento Valley Rd, Ste 217
San Diego
CA
CALIFORNIA
92121
Executive Officer
Chief Financial Officer
Biotechnology
Decline to Disclose
- 06b
false
2021-10-01
false
true
false
0
BOFA SECURITIES, INC.
283942
None
None
ONE BRYANT PARK
NEW YORK
NY
NEW YORK
10036
All States
true
99372730
58121796
41250934
false
78
4422553
true
0
accounts for potential fees payable on subsequent closings
0
false
Angiocrine Bioscience, Inc.
/s/ John Lomoro
John Lomoro
Chief Financial Officer
2021-10-15